2026-10-11T14:49:22Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34073944 2026-10-05T17:54:37Z category_4 category_19 category_734 category_132 portal_5 item_type_3 month_year_10_2026

<p>Comparative benchmark in conventional experimental evaluation. For the Nyamabo et al. setting, the mean and standard deviation across the three folds are shown. The best performance is shown in bold. † Results taken from Zitnik et al. [5].</p> Ruben Jimenez (25317319) Alberto Paccanaro (27961) Biochemistry Pharmacology Biological Sciences not elsewhere classified Infectious Diseases sampled negative examples realistic experimental settings data available prior balanced testing datasets tested drug combinations given drug combination drug combinations pose evaluations include warm side effect occurs drug pairs drug pair prospective evaluations side effects typically involve structured set start scenarios robust prediction results indicate restricted number major challenge key contribution introduce dcse highly imbalanced first evaluate clinical trials art methods already known <p>Comparative benchmark in conventional experimental evaluation. For the Nyamabo et al. setting, the mean and standard deviation across the three folds are shown. The best performance is shown in bold. † Results taken from Zitnik et al. [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013619#pcbi.1013619.ref005" target="_blank">5</a>].</p> 2026-10-05T17:54:30Z Dataset Dataset 10.1371/journal.pcbi.1013619.t001 https://figshare.com/articles/dataset/_p_Comparative_benchmark_in_conventional_experimental_evaluation_For_the_Nyamabo_et_al_setting_the_mean_and_standard_deviation_across_the_three_folds_are_shown_The_best_performance_is_shown_in_bold_Results_taken_from_Zitnik_et_al_5_p_/34073944 CC BY 4.0